I agree that this site is using cookies. You can find further informations here.
X
Patnaik, Mrinal
588  results:
Search for persons X
?
1

IDH-mutant myeloid neoplasms are associated with seronegati..:

Hong, Lih En ; Wechalekar, Mihir D. ; Kutyna, Monika...
Blood.  143 (2024)  18 - p. 1873-1877 , 2024
Link: https://doi.org/10.1182/..
 
?
2

Comprehensive morphologic characterization of bone marrow b..:

Olteanu, Horatiu ; Patnaik, Mrinal ; Koster, Matthew J...
American Journal of Clinical Pathology.  161 (2024)  6 - p. 609-624 , 2024
Link: https://doi.org/10.1093/..
 
?
3

Prognostic impact of SF3B1 mutation and multilineage dyspla..:

Farrukh, Faiqa ; Abdelmagid, Maymona ; Mangaonkar, Abhishek...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
4

Clinical and prognostic impact of STAG2 mutations in myeloi..:

Katamesh, Bahga ; Nanaa, Ahmad ; He, Rong...
Blood Advances.  7 (2023)  8 - p. 1351-1355 , 2023
Link: https://doi.org/10.1182/..
 
?
5

P-376 Genomic and transcriptional profiling stratifies myel..:

Flietner, Evan ; Yu, Mei ; Poudel, Govinda...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S247-S248 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Observation and treatment in DDX41-mutated acute myeloid le..:

Al-Kali, Aref ; Nanaa, Ahmad ; Viswanatha, David...
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
7

Granularity in disease classification impacts survival pred..:

Tefferi, Ayalew ; Abdelmagid, Maymona ; Al‐Kali, Aref...
American Journal of Hematology.  99 (2023)  1 - p. 21-27 , 2023
Link: https://doi.org/10.1002/..
 
?
8

P747: CLINICAL CHARACTERISTICS AND OUTCOME OF EZH2-MUTATED ..:

Oum, Muhamad ; Nanaa, Ahmad ; Mittapalli, Amrutha...
HemaSphere.  7 (2023)  S3 - p. e81209ff , 2023
Link: https://doi.org/10.1097/..
 
?
9

Molecular predictors of response and survival following IDH..:

Gangat, Naseema ; McCullough, Kristen ; Abdelmagid, Maymona...
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
10

Venetoclax plus hypomethylating agents in DDX41‐mutated acu..:

Nanaa, Ahmad ; He, Rong ; Foran, James M....
British Journal of Haematology.  204 (2023)  1 - p. 171-176 , 2023
Link: https://doi.org/10.1111/..
 
?
11

A phase II study of combination daunorubicin, cytarabine (A..:

Al‐Kali, Aref ; Tibes, Raoul ; Atherton, Pamela...
American Journal of Hematology.  98 (2023)  3 - p. 472-480 , 2023
Link: https://doi.org/10.1002/..
 
?
12

Characterization and Optimization of Multiomic Single-Cell ..:

Sandoval, Leticia ; Mohammed Ismail, Wazim ; Mazzone, Amelia...
Genes.  14 (2023)  6 - p. 1245 , 2023
Link: https://doi.org/10.3390/..
 
?
13

POSTER: AML-475 Activity, Tolerability, and Resistance Prof..:

Erba, Harry ; Wang, Eunice ; Issa, Ghayas...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S168 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Over 20% of patients report excessive alcohol use pre-trans..:

Kirsch, Janae L. ; Hogan, William ; Patnaik, Mrinal.
Bone Marrow Transplantation.  58 (2023)  5 - p. 581-583 , 2023
Link: https://doi.org/10.1038/..
 
?
15

P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUT..:

Basmaci, Rami ; Baranwal, Anmol ; He, Rong...
HemaSphere.  7 (2023)  S3 - p. e84724f8 , 2023
Link: https://doi.org/10.1097/..
 
1-15